PG
Paul Gama (CEO- Health Care) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in The Procter & Gamble Company (PG). The largest single filing was $698K of PG (4,331 sh × $161.27, as filed), executed Oct 23. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
4
0 buys · 4 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.0M
shares × price, as filed
Last traded
Oct 30
Filed Nov 3
Median ADV $1.3B across their filed names
Open performance→Volume by month
Buys $0
Sells $2.0M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Consumer Defensive
4 filings
Sector per market data · by filing · past 12 months
Most traded names
PGRecent filings
PGSALE
The Procter & Gamble Company
View filing →
$478K2,894 sh × $165.00
Exec Oct 30
Filed Nov 3 · 10:30 AM ET PGSALE The Procter & Gamble Company View filing → $698K
4,331 sh × $161.27
Exec Oct 23
Filed Oct 26 · 10:01 AM ET PGSALE The Procter & Gamble Company View filing → $323K
2,225 sh × $145.34
Exec Oct 5
Filed Oct 6 · 4:11 PM ET PGSALE The Procter & Gamble Company View filing → $488K
3,396 sh × $143.79
Exec Aug 20
Filed Aug 24 · 3:04 PM ET